Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
TIGR | 34.04% | $942.30M | +71.90% | 0.00% |
TTEC | 27.90% | $189.96M | -79.92% | 1.49% |
ZCMD | 27.03% | $35.55M | -56.76% | 0.00% |
TECX | 26.58% | $619.91M | +161.32% | 0.00% |
LBRDA | 26.41% | $10.74B | -1.31% | 0.00% |
SOL | 26.00% | $109.71M | +2.46% | 0.00% |
GHI | 25.81% | $278.09M | -26.17% | 12.62% |
FUTU | 24.98% | $7.52B | +78.48% | 0.00% |
NOAH | 24.88% | $703.52M | -2.13% | 9.97% |
LBRDK | 24.43% | $10.84B | -0.95% | 0.00% |
WB | 24.40% | $1.46B | +25.35% | 0.00% |
BASE | 23.41% | $856.41M | -30.85% | 0.00% |
ZTO | 22.30% | $11.25B | +5.97% | 5.07% |
JD | 22.16% | $49.05B | +60.85% | 2.04% |
LLYVK | 21.77% | $6.41B | +93.35% | 0.00% |
JKS | 21.21% | $1.21B | -17.61% | 0.00% |
DHC | 20.71% | $501.85M | -25.71% | 1.90% |
TME | 20.33% | $7.28B | +18.86% | 1.31% |
ARCT | 20.25% | $460.76M | -47.29% | 0.00% |
IQ | 20.23% | $982.16M | -50.00% | 0.00% |
Current Value
$13.561 Year Return
Current Value
$13.561 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IBN | -<0.01% | $101.66B | +22.87% | 0.84% |
BLBD | 0.01% | $1.37B | +69.40% | 0.00% |
MOH | 0.01% | $16.16B | -25.84% | 0.00% |
AS | -0.02% | $16.34B | +130.00% | 0.00% |
CASY | 0.02% | $14.51B | +37.09% | 0.47% |
TBBK | -0.03% | $2.66B | +45.85% | 0.00% |
VSTS | -0.03% | $2.16B | -20.11% | 0.85% |
LUNR | -0.04% | $1.72B | +641.63% | 0.00% |
COLM | 0.04% | $4.74B | +6.89% | 1.43% |
STTK | -0.05% | $52.04M | -87.12% | 0.00% |
GTLB | 0.06% | $10.42B | -1.38% | 0.00% |
BACK | 0.06% | $2.66M | -40.81% | 0.00% |
BBVA | -0.06% | $61.49B | +21.62% | 6.88% |
PEP | 0.07% | $201.05B | -12.34% | 3.61% |
PSN | 0.07% | $10.13B | +44.20% | 0.00% |
SUPV | 0.07% | $1.42B | +356.74% | 0.94% |
IMAX | -0.08% | $1.18B | +58.01% | 0.00% |
IRON | 0.08% | $1.78B | -3.42% | 0.00% |
NARI | 0.08% | $4.65B | +36.85% | 0.00% |
LANC | -0.09% | $4.69B | -1.70% | 2.13% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LNW | -19.62% | $7.88B | +8.52% | 0.00% |
CCRN | -16.77% | $584.87M | -16.30% | 0.00% |
CYCN | -16.21% | $7.89M | -19.17% | 0.00% |
LVO | -14.82% | $111.93M | -12.69% | 0.00% |
SRRK | -13.71% | $4.11B | +176.62% | 0.00% |
STLA | -13.48% | $36.22B | -41.74% | 12.69% |
PSQH | -10.77% | $195.63M | -11.07% | 0.00% |
SEG | -10.46% | $337.96M | +3.29% | 0.00% |
MCK | -10.37% | $75.55B | +20.73% | 0.45% |
GAN | -9.42% | $84.76M | +16.98% | 0.00% |
CAH | -9.03% | $30.74B | +19.40% | 1.59% |
APT | -8.96% | $61.59M | +10.24% | 0.00% |
LPL | -8.91% | $3.18B | -36.27% | 0.00% |
COR | -8.80% | $46.56B | +9.10% | 0.86% |
OCX | -8.54% | $35.35M | -36.56% | 0.00% |
FWONK | -7.93% | $22.38B | +43.08% | 0.00% |
KB | -7.83% | $23.35B | +67.59% | 4.62% |
CATO | -7.82% | $76.81M | -47.47% | 13.42% |
FWONA | -7.73% | $20.41B | +44.79% | 0.00% |
V | -7.70% | $622.14B | +18.32% | 0.68% |
Yahoo
Capricor stock gains 8% upon completing the rolling submission of the BLA for its lead asset, deramiocel, to treat DMD cardiomyopathy in the United States.
Finnhub
Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy -If approved,...
Yahoo
-If approved, deramiocel would be first approved therapy for Duchenne muscular dystrophy cardiomyopathy- -BLA submission triggers $10 million milestone payment to Capricor from Nippon Shinyaku- SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the completion of the submission of its Biologics License Application (BLA) to the U.
Finnhub
Capricor Therapeutics, Inc. added to S&P Biotechnology Select Industry Index...
Yahoo
The United States market has remained flat over the last week but is up 29% over the past year, with earnings expected to grow by 15% per annum. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for revenue expansion and innovation while aligning with broader market trends.
SeekingAlpha
Capricor Therapeutics is advancing deramiocel for DMD-related cardiomyopathy, with FDA approval potential by 2025. Read why CAPR stock is a speculative buy.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ULST | -11.21% | $549.72M | 0.2% |
VIXY | -10.32% | $195.31M | 0.85% |
TAIL | -9.92% | $65.23M | 0.59% |
VNLA | -9.50% | $2.33B | 0.23% |
KMLM | -7.61% | $330.04M | 0.9% |
XBIL | -7.58% | $643.80M | 0.15% |
FTSM | -7.42% | $6.25B | 0.45% |
XONE | -7.35% | $571.79M | 0.03% |
IVOL | -7.11% | $457.45M | 1.02% |
XHLF | -6.44% | $943.05M | 0.03% |
YEAR | -6.40% | $1.19B | 0.25% |
IBTG | -6.30% | $1.65B | 0.07% |
UTWO | -6.26% | $389.61M | 0.15% |
PWZ | -5.75% | $695.89M | 0.28% |
SUB | -5.59% | $8.70B | 0.07% |
PREF | -5.31% | $1.06B | 0.55% |
GBIL | -5.16% | $5.81B | 0.12% |
DUSB | -5.12% | $939.32M | 0.15% |
SHY | -4.26% | $22.82B | 0.15% |
SGOV | -4.17% | $31.44B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PGJ | 21.38% | $134.84M | 0.67% |
PICK | 20.62% | $786.36M | 0.39% |
CQQQ | 20.11% | $631.36M | 0.65% |
CXSE | 19.47% | $367.78M | 0.32% |
AGZD | 19.32% | $148.43M | 0.23% |
BATT | 19.31% | $65.99M | 0.59% |
HERO | 18.81% | $99.08M | 0.5% |
WOOD | 18.70% | $237.26M | 0.41% |
DVYE | 18.65% | $624.96M | 0.49% |
GXC | 18.60% | $388.10M | 0.59% |
FLCH | 18.45% | $142.24M | 0.19% |
BKLN | 18.45% | $9.56B | 0.65% |
KWEB | 18.43% | $5.15B | 0.7% |
INFL | 18.29% | $1.08B | 0.85% |
COPX | 18.07% | $2.67B | 0.65% |
XME | 17.99% | $1.58B | 0.35% |
FXI | 17.96% | $6.88B | 0.74% |
FTQI | 17.54% | $551.17M | 0.75% |
FDVV | 17.50% | $4.40B | 0.16% |
FTHI | 17.44% | $1.10B | 0.75% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHV | 0.01% | $18.98B | 0.15% |
EDV | 0.02% | $3.80B | 0.06% |
STIP | -0.04% | $10.80B | 0.03% |
USDU | -0.05% | $396.64M | 0.5% |
UDN | -0.06% | $47.38M | 0.78% |
SCHR | 0.09% | $10.07B | 0.03% |
TLT | 0.10% | $51.71B | 0.15% |
IBTO | -0.11% | $262.64M | 0.07% |
IBTK | -0.18% | $328.40M | 0.07% |
IBD | -0.21% | $337.54M | 0.44% |
BILZ | -0.22% | $616.99M | 0.14% |
IEF | 0.25% | $31.44B | 0.15% |
UCON | 0.28% | $3.37B | 0.85% |
IBDS | 0.30% | $2.82B | 0.1% |
EWS | -0.34% | $593.27M | 0.5% |
OWNS | 0.37% | $126.36M | 0.3% |
NEAR | -0.39% | $2.99B | 0.25% |
TYA | 0.40% | $106.10M | 0.15% |
VGLT | 0.40% | $9.64B | 0.04% |
BSCQ | 0.42% | $4.23B | 0.1% |